These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 8401517)

  • 1. Identification of type I collagen gene (COL1A2) mutations in nonlethal osteogenesis imperfecta.
    Sztrolovics R; Glorieux FH; van der Rest M; Roughley PJ
    Hum Mol Genet; 1993 Aug; 2(8):1319-21. PubMed ID: 8401517
    [No Abstract]   [Full Text] [Related]  

  • 2. Recurrence of lethal osteogenesis imperfecta due to parental mosaicism for a mutation in the COL1A2 gene of type I collagen. The mosaic parent exhibits phenotypic features of a mild form of the disease.
    Edwards MJ; Wenstrup RJ; Byers PH; Cohn DH
    Hum Mutat; 1992; 1(1):47-54. PubMed ID: 1301191
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lethal perinatal osteogenesis imperfecta due to a type I collagen alpha 2(I) Gly to Arg substitution detected by chemical cleavage of an mRNA:cDNA sequence mismatch.
    Bateman JF; Moeller I; Hannagan M; Chan D; Cole WG
    Hum Mutat; 1992; 1(1):55-62. PubMed ID: 1284475
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Substitution of an aspartic acid for glycine 700 in the alpha 2(I) chain of type I collagen in a recurrent lethal type II osteogenesis imperfecta dramatically affects the mineralization of bone.
    Cohen-Solal L; Zylberberg L; Sangalli A; Gomez Lira M; Mottes M
    J Biol Chem; 1994 May; 269(20):14751-8. PubMed ID: 8182080
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of a type I collagen alpha 2(I) glycine-586 to valine substitution in osteogenesis imperfecta type IV. Detection of the mutation and prenatal diagnosis by a chemical cleavage method.
    Bateman JF; Hannagan M; Chan D; Cole WG
    Biochem J; 1991 Jun; 276 ( Pt 3)(Pt 3):765-70. PubMed ID: 2064612
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of three osteogenesis imperfecta collagen alpha 1(I) glycine to serine mutations demonstrating a position-dependent gradient of phenotypic severity.
    Bateman JF; Moeller I; Hannagan M; Chan D; Cole WG
    Biochem J; 1992 Nov; 288 ( Pt 1)(Pt 1):131-5. PubMed ID: 1445258
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serine for glycine substitutions in the C-terminal third of the alpha 1(I) chain of collagen I in five patients with nonlethal osteogenesis imperfecta.
    Lund AM; Skovby F; Schwartz M
    Hum Mutat; 1997; 9(4):378-82. PubMed ID: 9101304
    [No Abstract]   [Full Text] [Related]  

  • 8. Osteogenesis imperfecta phenotypes resulting from serine for glycine substitutions in the alpha2(I) collagen chain.
    Nuytinck L; Wettinck K; Freund M; Van Maldergem L; Fabry G; De Paepe A
    Eur J Hum Genet; 1997; 5(3):161-7. PubMed ID: 9272740
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of point mutations in the collagen COL1A1 and COL1A2 genes causing lethal perinatal osteogenesis imperfecta.
    Lamande SR; Dahl HH; Cole WG; Bateman JF
    J Biol Chem; 1989 Sep; 264(27):15809-12. PubMed ID: 2777764
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Substitution of glycine-172 by arginine in the alpha 1 chain of type I collagen in a patient with osteogenesis imperfecta, type III.
    Mackay K; De Paepe A; Nuytinck L; Dalgleish R
    Hum Mutat; 1994; 3(3):324-6. PubMed ID: 8019571
    [No Abstract]   [Full Text] [Related]  

  • 11. Low basal transcription of genes for tissue-specific collagens by fibroblasts and lymphoblastoid cells. Application to the characterization of a glycine 997 to serine substitution in alpha 1(II) collagen chains of a patient with spondyloepiphyseal dysplasia.
    Chan D; Cole WG
    J Biol Chem; 1991 Jul; 266(19):12487-94. PubMed ID: 1905723
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Gly238Ser substitution in the alpha 2 chain of type I collagen results in osteogenesis imperfecta type III.
    Rose NJ; Mackay K; Byers PH; Dalgleish R
    Hum Genet; 1995 Feb; 95(2):215-8. PubMed ID: 7860070
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recurrent mutations in the COL1A2 gene in patients with osteogenesis imperfecta.
    Trummer T; Brenner R; Just W; Vogel W; Kennerknecht I
    Clin Genet; 2001 May; 59(5):338-43. PubMed ID: 11359465
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Paternal mosaicism for a COL1A1 dominant mutation (alpha 1 Ser-415) causes recurrent osteogenesis imperfecta.
    Mottes M; Gomez Lira MM; Valli M; Scarano G; Lonardo F; Forlino A; Cetta G; Pignatti PF
    Hum Mutat; 1993; 2(3):196-204. PubMed ID: 8364588
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Osteogenesis imperfecta: comparison of molecular defects with bone histological changes.
    Sztrolovics R; Glorieux FH; Travers R; van der Rest M; Roughley PJ
    Bone; 1994; 15(3):321-8. PubMed ID: 7520724
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutations in the COL1A2 gene of type I collagen that result in nonlethal forms of osteogenesis imperfecta.
    Wenstrup RJ; Lever LW; Phillips CL; Quarles LD
    Am J Med Genet; 1993 Jan; 45(2):228-32. PubMed ID: 8456807
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutation in a gene for type I procollagen (COL1A2) in a woman with postmenopausal osteoporosis: evidence for phenotypic and genotypic overlap with mild osteogenesis imperfecta.
    Spotila LD; Constantinou CD; Sereda L; Ganguly A; Riggs BL; Prockop DJ
    Proc Natl Acad Sci U S A; 1991 Jun; 88(12):5423-7. PubMed ID: 2052622
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recurrence of osteogenesis imperfecta because of paternal mosaicism: Gly862-->Ser substitution in a type I collagen gene (COL1A1).
    Namikawa C; Suzumori K; Fukushima Y; Sasaki M; Hata A
    Hum Genet; 1995 Jun; 95(6):666-70. PubMed ID: 7789952
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutations that substitute serine for glycine alpha 1-598 and glycine alpha 1-631 in type I procollagen. The effects on thermal unfolding of the triple helix are position-specific and demonstrate that the protein unfolds through a series of cooperative blocks.
    Westerhausen A; Kishi J; Prockop DJ
    J Biol Chem; 1990 Aug; 265(23):13995-4000. PubMed ID: 2116413
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A dominant mutation in the COL1A1 gene that substitutes glycine for valine causes recurrent lethal osteogenesis imperfecta.
    Bonaventure J; Cohen-Solal L; Lasselin C; Maroteaux P
    Hum Genet; 1992 Aug; 89(6):640-6. PubMed ID: 1511982
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.